
Tempus | AI-enabled precision medicine
Tempus has built the world’s largest library of clinical & molecular data and an operating system to make that data accessible and useful, starting with cancer.
Home - Tempus Unlimited
Tempus Unlimited exists to provide a continuum of community based services that support the efforts of children and adults with disabilities to live as independently as possible in the least …
Tempus AI - Wikipedia
Tempus uses data and artificial intelligence (AI) to create precision medicine services, including diagnostics, [5] for oncology, cardiology, radiology, and depression. The company went public …
Tempus - compcancercare.com
TEMPUS® is a technology company that has built the world's largest library of clinical and molecular data and an operating system to make that information accessible and useful for …
Tempus Announces Preliminary Fourth Quarter and Full Year ...
5 days ago · Tempus plans to report its complete fourth quarter and full year 2025 financial results during its earnings call in February 2026. About Tempus
Why Is Tempus AI Stock Soaring Monday? - Benzinga
3 days ago · Tempus AI (NASDAQ: TEM) stock rose after releasing preliminary Q4 and 2025 results, with revenue of $1.27B in 2025 and $367M in Q4.
Welcome to Tempus Patient Portal
In order to access your patient portal, look for an email from Tempus with instructions to create your password and access your patient portal. Monitor your PGx order status, and receive …